Cargando…
Changes in intraocular pressure in study and fellow eyes in the IVAN trial
PURPOSE: To describe changes in intraocular pressure (IOP) in the ‘alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)’ trial (registered as ISRCTN92166560). DESIGN: Randomised controlled clinical trial with factorial design. PARTICIPANTS: Patients (n=610) with...
Autores principales: | Foss, Alexander J E, Scott, Lauren J, Rogers, Chris A, Reeves, Barney C, Ghanchi, Faruque, Gibson, Jonathan, Chakravarthy, Usha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256412/ https://www.ncbi.nlm.nih.gov/pubmed/27073205 http://dx.doi.org/10.1136/bjophthalmol-2015-307595 |
Ejemplares similares
-
Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events
por: Rogers, Chris A., et al.
Publicado: (2018) -
Modelling of longitudinal outcomes with highly skewed distributions: applications in the IVAN trial
por: Nash, R, et al.
Publicado: (2013) -
Positional Intraocular Pressure of Vitrectomized and Normal Fellow Eyes
por: Lee, Jae Hyuck, et al.
Publicado: (2018) -
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial
por: Evans, Rebecca N., et al.
Publicado: (2020) -
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
por: Dakin, Helen A, et al.
Publicado: (2014)